UCFA
IMMU

United Capital Financial Advisors’s Immunomedics Inc IMMU Stock Holding History

United Capital Financial Advisors’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-15,539
Closed -$39K – 1302
2016
Q1 		$39K Buy
+15,539
New +$34.9K ﹤0.01% 1198

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

United Capital Financial Advisors's IMMU Position: Q2 2016 in Review

United Capital Financial Advisors sold out of Immunomedics Inc (IMMU) in Q2 2016, closing a stake of 15,539 shares — an estimated $39K sold.

United Capital Financial Advisors first reported a position in IMMU in Q1 2016 and held it in 1 quarter. The position peaked at $39K in Q1 2016. 110 funds tracked by Wall St. Rank hold IMMU as of Q2 2016.

  • United Capital Financial Advisors reported no remaining Immunomedics Inc position as of Q2 2016 after selling out during the quarter.
  • United Capital Financial Advisors sold 15,539 Immunomedics Inc shares in Q2 2016, an estimated $39K.
  • United Capital Financial Advisors first reported a position in Immunomedics Inc in Q1 2016 and held it in 1 quarter.
  • United Capital Financial Advisors's Immunomedics Inc position peaked at $39K in Q1 2016.
  • 110 funds tracked by Wall St. Rank held Immunomedics Inc as of Q2 2016.

Based on United Capital Financial Advisors's 13F filing for Q2 2016, filed 15 Aug 2016.